Other genes, including PLK1, CDCA8, ANLN, and RACGAP1, were all discovered to play different roles in proliferation, metastasis, and enhanced chemotherapy sensitivity to doxorubicin in lung cancer (De Carcer et al., 2018; Ge et al., 2019; Xu et al., 2019; Hu et al., 2021). This evidence concerns the gene CDCA8 and lung carcinoma.